Results 211 to 220 of about 157,060 (341)

Associations between steatotic liver disease subtypes and incident diabetes in young Korean adults: A nationwide cohort study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims The impact of steatotic liver disease (SLD) subtypes on incident type 2 diabetes remains unclear. We investigated the association of metabolic dysfunction‐associated steatotic liver disease (MASLD), MetALD (MASLD with moderate alcohol consumption), and alcohol‐related liver disease (ALD) with incident type 2 diabetes in Korean adults aged
Goh Eun Chung, Su Jong Yu, Jeayeon Park, Yoon Jun Kim, Jung‐Hwan Yoon, Kyungdo Han, Eun Ju Cho   +6 more
wiley   +1 more source

A Study of the Prescription Patterns of Antihypertensive Drugs in Patients Attending the Outpatient Department of Medicine at a Tertiary Care Hospital. [PDF]

Cureus
Shankpal PD, Lohi SM, Karande S, Bonde VN.   +3 more
europepmc   +1 more source

A Comparative Study between Antihypertensive Drugs (Methyldopa, Labetalol, and Nifedipine) in Pre-Eclamptic Women: A Randomized Controlled Trial [PDF]

Magdy Selim, Mohamed Elsharawy, Shereef L. Elshwaikh, Ahmed Abou Freikha   +3 more
openalex   +1 more source

Literature‐informed ensemble machine learning for three‐year diabetic kidney disease risk prediction in type 2 diabetes: Development, validation, and deployment of the PSMMC NephraRisk model

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Introduction Diabetic kidney disease (DKD) and diabetic nephropathy (DN) affect around 40% of diabetic patients but lack accurate risk prediction tools that include social determinants and demographic complexity. We developed and validated an ensemble machine learning model for three‐year DKD/DN risk prediction with deployment readiness ...
Ayla M. Tourkmani, Turki J. Al‐Harbi, Ahmad Abdullah Alghamdi, Ibrahim M. Youzghadli, Faris Saad Alosaimi, Ahmed Y. Azzam   +5 more
wiley   +1 more source

Safety of antihypertensive drugs – a network meta-analysis of double blind randomized clinical trials [PDF]

Anthony Rodgers, Abdul Salam, Stephen Vander Hoorn, Nelson Wang   +3 more
openalex   +1 more source

Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double‐blind, multicentre, therapeutic confirmatory phase 3 clinical trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim This study evaluated the efficacy and safety of empagliflozin 10 and 25 mg compared to placebo as add‐on treatment for people with type 2 diabetes mellitus (T2DM) uncontrolled after ≥8 weeks of treatment with metformin and sitagliptin. Materials and Methods A randomised, double‐blind, multicentre, therapeutic confirmatory, phase 3 clinical
Seung‐Hwan Lee, Kyung Ah Han, Eun‐Gyoung Hong, Jun Goo Kang, Choon Hee Chung, Jong Chul Won, Eon Ju Jeon, Jung‐Hwan Cho, Ho Chan Cho, Sin Gon Kim, Eun Seok Kang, So Hun Kim, Hae Jin Kim, In‐Kyung Jeong, Sung Wan Chun, Young Min Cho   +15 more
wiley   +1 more source

Effect of antihypertensive drugs on survival in patients with non-small cell lung cancer on epidermal growth factor receptor inhibitors. [PDF]

Am J Cancer Res
Hsieh HH, Wu TY, Lee WY, Chen CH, Kuo YH, Lee HZ, Hour MJ.   +6 more
europepmc   +1 more source

Resistant hypertension and renal denervation: Who's kidding whom? [PDF]

, 2014
Sever, P
core   +1 more source

Interaction of antihypertensive drugs with atorvastatin in hyperlipidemic cardiac patients

, 2012
Muhammad Sohail, Khalid Hussain Janbaz, Saeed Ahmad, Tariq Abbas   +3 more
openalex   +1 more source

Effects of antihypertensive single-drug therapy on heart rate [PDF]

, 1999
Barry J. Materson
openalex   +1 more source